|
US2021113610A1
|
|
Treatment for autistic spectrum disorder (asd) and relevant symptoms
|
|
US2021113179A1
|
|
Methods of enhancing the accuracy and/or sensitivity of ultrasound imaging in diagnosing tumors
|
|
GB202016022D0
|
|
Nanoparticle for anti-cancer peptides and uses thereof
|
|
WO2021067324A1
|
|
Methods of treating pompe disease
|
|
WO2021055679A1
|
|
Chimeric hemagglutinin protein and a vaccine composition comprising the same
|
|
WO2021055587A1
|
|
Method for improving growth, stress tolerance and productivity of plant, and increasing seed quality of plant
|
|
WO2021042082A1
|
|
Nanocomposite particle and uses thereof
|
|
WO2021026176A1
|
|
Micro-reactor and method of use
|
|
WO2021025978A1
|
|
Recombinant baculovirus displaying african swine fever virus proteins, and an immunological composition comprising the same
|
|
WO2021021866A1
|
|
Nanocomposite and uses thereof
|
|
WO2021016141A1
|
|
Anti-coccidial phytogenic formulations
|
|
WO2020247290A1
|
|
Ligands targed to epidermal growth factor receptors and compositions for use in treating tumors
|
|
WO2020237010A1
|
|
Method for amplifying and detecting ribonucleic acid (rna) fragments
|
|
US2020362030A1
|
|
Caveolin-1 antibody for use in treating brain inflammation and injury and improving functional recovery
|
|
WO2020232034A1
|
|
Lama2, plxdc2 and mll4 as novel biomarkers for prediabetes and diabetes
|
|
WO2020231788A1
|
|
A vaccine comprising a nanoparticle encapsulating epitopes and adjuvant for neutraliying virus infection
|
|
WO2020231764A1
|
|
Dynamic data correction method and apparatus for generating a high resolution spectrum
|
|
WO2020214836A1
|
|
Methods of coating antimicrobial peptides on the biomaterial and the biomaterial coated thereby
|
|
US2020332239A1
|
|
Microwell device and method of manufacturing the same
|
|
US2020330449A1
|
|
4(1h)-quinolone derivatives and uses thereof
|
